The Privatization of Veterans' Healthcare | ft. Dr. Rachel Madley

Private insurance companies are increasingly moving into veterans' healthcare and, according to health policy expert Dr. Rachel Madley, the consequences could reshape one of America’s most successful public healthcaresystems.In this week’s episode, Chuck welcomes Dr. Madley to talk about about the growing privatization of the VA through the Veterans Community Care Program and the VA Mission Act.They explore how companies like UnitedHealth Group and Optum Serve are gaining influence inside public healthcare programs, why many experts see concerning parallels with Medicare Advantage, and what this means for veterans, taxpayers, and the future of healthcare reform in the United States.The conversation covers the economics of privatization, conflicts of interest in healthcare administration, the political influence of insurance lobbying, and why the VA often delivers better outcomes at lower cost than private systems.Dr. Madley also explains why she believes reinvesting in VA facilities and staffing would strengthen care for veterans far more effectively than outsourcing administration to private insurers.Topics include:• The VA Mission Act and Community Care• Medicare Advantage and privatization trends in public care• Healthcare lobbying and political influence• Optum Serve and vertical integration concerns• Traditional Medicare versus private insurance administration• Why veterans’ care matters to all taxpayersOur GuestDr. Rachel Madley is Executive Director of the Center for Health and Democracy, a nonpartisan nonprofit advancing policy reforms to lower health care costs and expand access to care. She brings a rare combination of scientific expertise, Capitol Hill experience, and personal perspective as someone living with Type 1 diabetes. Notably, she contributed to the passage of the Inflation Reduction Act as Health Policy Advisor to Congresswoman Pramila Jayapal. Dr. Madley holds a PhD in Microbiology and Immunology from Columbia University and her work has been featured in The New York Times, Newsweek, and Business Insider.